Medicare

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results

– Reports YCANTH® revenue of $3.2M for first quarter of 2024 – – Over 228 million lives now covered to date…

6 months ago

Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health Solution”

This marks the fourth consecutive year that Castle has earned a MedTech Breakthrough Award for its innovative testing solutionsFRIENDSWOOD, Texas--(BUSINESS…

7 months ago

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

Eversense® CGM+RPM solution to be powered by Rimidi’s clinical management platformGERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical…

7 months ago

Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwindsPALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc.…

7 months ago

With Vim as a Strategic Technology Partner, Pearl Health Launches Enhanced EHR Experience

NEW YORK--(BUSINESS WIRE)--Vim, a leading middleware platform for clinical workflow integration, and Pearl Health, a leading technology company focused on…

7 months ago

LENSAR Reports First Quarter 2024 Results and Provides Business Update

Total Revenue increased 28% and Procedure volume increased 25% over the first quarter of 2023 Increased ALLY® Adaptive Cataract Treatment…

7 months ago

NHI Files Supplemental Proxy

MURFREESBORO, TN / ACCESSWIRE / May 7, 2024 / National Health Investors, Inc. (NYSE:NHI) filed a proxy statement supplement (the…

7 months ago

NHI Announces Second Quarter 2024 Dividend

MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay…

7 months ago

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

CMS establishes new Medicare coverage codes for the one-step automatic blood glucose monitor, expanding access to millions of seniors living…

7 months ago

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer…

7 months ago